LONDON BROKER RATINGS: Stifel prefers AstraZeneca over GlaxoSmithKline
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read more(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read more(Alliance News) - Oil major BP said its decision to exit its stake in Russia's Rosneft will not harm its ability to increase payouts.
Read more(Sharecast News) - Analysts at Berenberg restarted coverage on software firm Aveva with a 'buy' rating and 3,550.0p target price on Friday following its acquisition of OSIsoft.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
Read more(Alliance News) - UK state-backed lender NatWest on Friday reported a profit for 2021 and said it plans to return GBP750 million to shareholders via a share buyback, and possibly even more.
Read more(Alliance News) - Aveva Group PLC on Thursday said its pipeline for the remainder of its financial year is "solid" and it has requested Chair Philip Aiken stay in his role for a further year.
Read more(Sharecast News) - Aveva reported solid growth in the third quarter and targeted faster revenue growth to come as the industrial software group left its guidance for the current year intact.
Read more(Alliance News) - Stock prices in London are seen opening slightly lower on Thursday following an uncertain handover from Asia, as investors mull the possibility of quick interest rate hikes from the Federal Reserve, in addition to ongoing tensions between Russia and Ukraine.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreLONDON BROKER RATINGS: JPMorgan likes Prudential, Aviva in insurance
Read moreLONDON BROKER RATINGS: Bank of America raises Tesco and cuts Unilever
Read moreLONDON MARKET CLOSE: Hawkish Federal Reserve minutes unnerve markets
Read moreEngineer Weir eyes reduction of Scope 3 carbon emissions at customers
Read more